Varma, Adarsh
Trudeau, Sheri
Zhou, Yueren
Jafri, Syed-Mohammed
Krajenta, Richard
Lamerato, Lois
Brown, Kimberly
Luzzi, Veronica
Lu, Mei
Gordon, Stuart C.
Funding for this research was provided by:
Henry Ford Health System
Article History
Received: 15 May 2020
Revised: 27 October 2020
Accepted: 28 October 2020
First Online: 23 November 2020
Compliance with Ethical Standards
: All protocols were reviewed and approved by the HFHS Institutional Review Board prior to study initiation. The requirement for written informed consent was waived due to the observational nature of the study and the use of de-identified data.
: Stuart C. Gordon receives grant/research support from AbbVie Inc., Conatus Pharmaceuticals, CymaBay Therapeutics, Gilead Pharmaceuticals, Intercept Pharmaceuticals, and Merck & Co. He serves as an ad hoc consultant/advisor for Abbvie Inc., CVS Caremark, Gilead Pharmaceuticals, Intercept Pharmaceuticals, and Merck & Co.Kimberly Brown receives grant/research support from Novartis, Gilead Pharmaceuticals, Conatus Pharmaceuticals, and Allergan. She has served as an advisor for Merck & Co, Gilead Pharmaceuticals, and AbbVie Inc.Sheri Trudeau, Yueren Zhou, and Mei Lu receive grant/research support from Gilead Pharmaceuticals.Lois Lamerato receives research support from AstraZeneca, Pfizer inc, Merck & Co, Policy Analysis Inc., Analytica International, Xcenda, eMaxHealth, and Evidera.Adarsh Varma, Syed-Mohammed Jafri, Richard Krajenta, and Veronica Luzzi have no potential conflicts of interest to disclose.